In Heart disease COENATTO PLUS CAPSULE is a medicine that helps treat heart disease. It prevents formation of blood clots that can cause damage to the blood vessels. It also relieves the inflammation associated with heart disease. This reduces the chances of heart diseases and helps you remain healthier for longer. COENATTO PLUS CAPSULE helps in boosting body energy levels and speedy recovery. Take it regularly and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Keep taking it even if you feel well. However, consult your doctor before taking it to get maximum benefit.
Caution is advised when consuming alcohol with COENATTO PLUS CAPSULE. Please consult your doctor.
Information regarding the use of COENATTO PLUS CAPSULE during pregnancy is not available. Please consult your doctor.
Information regarding the use of COENATTO PLUS CAPSULE during breastfeeding is not available. Please consult your doctor.
It is not known whether COENATTO PLUS CAPSULE alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
COENATTO PLUS CAPSULE is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of COENATTO PLUS CAPSULE may not be needed in these patients. Please consult your doctor.
COENATTO PLUS CAPSULE is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of COENATTO PLUS CAPSULE may not be needed in these patients. Please consult your doctor.
If you miss a dose of COENATTO PLUS CAPSULE, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More